JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB6757

Rabbit Anti-Human IgG H&L (Texas Red ®)

Be the first to review this product! Submit a review

|

(10 Publications)

Suitable for ChIP, Flow Cyt, IHC-Fr, IHC-P, IM, ELISA, ICC/IF. Cited in 10 publications.

View Alternative Names

Immunoglobulin heavy constant gamma 1, Ig gamma-1 chain C region, Ig gamma-1 chain C region EU, Ig gamma-1 chain C region KOL, Ig gamma-1 chain C region NIE, IGHG1, Immunoglobulin heavy constant gamma 4, Ig gamma-4 chain C region, IGHG4, Immunoglobulin heavy constant gamma 3, HDC, Heavy chain disease protein, Ig gamma-3 chain C region, IGHG3, Immunoglobulin heavy constant gamma 2, Ig gamma-2 chain C region, Ig gamma-2 chain C region DOT, Ig gamma-2 chain C region TIL, Ig gamma-2 chain C region ZIE, IGHG2

Key facts

Host species

Rabbit

Target species

Human

Target isotype

IgG

Target specificity

Heavy & Light chains

Minimal cross-reactivity
Pre-adsorbed

No

Conjugation

Texas Red®

Excitation/Emission

Ex: 589nm, Em: 615nm

Applications

Flow Cyt, IHC-Fr, ICC/IF, ChIP, IHC-P, IM, ELISA

applications

Clonality

Polyclonal

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "ChIP": { "reactivity":"NO_EXPERIMENTAL_DATA_EXPECTED_TO_REACT", "dilution-info":"", "notes":"<p></p>" }, "Flow Cyt": { "reactivity":"NO_EXPERIMENTAL_DATA_EXPECTED_TO_REACT", "dilution-info":"", "notes":"<p></p>" }, "IHC-Fr": { "reactivity":"NO_EXPERIMENTAL_DATA_EXPECTED_TO_REACT", "dilution-info":"", "notes":"<p></p>" }, "IHC-P": { "reactivity":"NO_EXPERIMENTAL_DATA_EXPECTED_TO_REACT", "dilution-info":"", "notes":"<p></p>" }, "IM": { "reactivity":"NO_EXPERIMENTAL_DATA_EXPECTED_TO_REACT", "dilution-info":"", "notes":"<p></p>" }, "ELISA": { "reactivity":"NO_EXPERIMENTAL_DATA_EXPECTED_TO_REACT", "dilution-info":"1/10000 - 1/50000", "notes":"<p></p>" }, "ICC/IF": { "reactivity":"NO_EXPERIMENTAL_DATA_EXPECTED_TO_REACT", "dilution-info":"1/1000 - 1/5000", "notes":"<p></p>" } } }

Properties and storage information

Form
Liquid
Purification technique
Affinity purification
Purification notes
This product was prepared from monospecific antiserum by immunoaffinity chromatography using Human IgG coupled to agarose beads followed by solid phase adsorption(s) to remove any unwanted reactivities.
Storage buffer
Preservative: 0.01% Sodium azide Constituents: 1% BSA, 0.88% Sodium chloride, 0.424% Potassium phosphate solution
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Product protocols

Target data

Constant region of immunoglobulin (Ig) heavy chains. Igs are membrane-bound or secreted glycoproteins produced by B lymphocytes. In the recognition phase of humoral immunity, the membrane-bound Igs serve as receptors, which upon binding to a specific antigen trigger the clonal expansion and differentiation of B lymphocytes into Ig-secreting plasma cells. Secreted Igs known as antibodies mediate the effector phase of humoral immunity by blocking the interaction of infectious antigens with cellular receptors (via the antigen-binding region) and eliciting effector mechanisms that lead to pathogen neutralization (via the constant region) (PubMed : 17576170, PubMed : 20176268, PubMed : 22158414). The antigen-binding region is formed by the variable domain of one heavy chain paired with the variable domain of its associated light chain. Each Ig molecule has two antigen-binding sites with remarkable affinity for a particular antigen due to V-(D)-J rearrangement, somatic hypermutations and affinity maturation of the variable domains upon antigen exposure (PubMed : 17576170, PubMed : 20176268, PubMed : 22158414). The constant region defines the Ig isotype that perform distinct sets of effector functions. B cells diversify and rearrange their Ig constant regions through class-switch recombination, a process by which the constant region is switched from one Ig isotype to another, namely from IgM and IgD to IgG, IgA and IgE (PubMed : 17576170, PubMed : 20176268, PubMed : 22158414). The constant region of Ig gamma-1 (IgG1) isotype interacts (via the fragment crystallizable, Fc) with receptors on innate immune cells and the complement system to mediate humoral effector functions, including antibody-dependent cellular cytotoxicity or phagocytosis, complement-dependent cytotoxicity and inflammatory responses.
See full target information IGHG1

Additional targets

IGHG4,IGHG3,IGHG2

Publications (10)

Recent publications for all applications. Explore the full list and refine your search

Molecular medicine (Cambridge, Mass.) 30:267 PubMed39716068

2024

RBM15-dependent m6A modification mediates progression of non-small cell lung cancer cells.

Applications

Unspecified application

Species

Unspecified reactive species

Man Wang,Yujiao Qin,Xiaoqi Ai,Xiuhua Liu

Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion 76:185-194 PubMed39419019

2024

LINC01614 activated by SP1 promoted malignant behavior of triple-negative breast cancer cells via the WNT/b-Catenin signaling pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Tao Chen,Kenzi Shi,Shengrong Sun

Biomolecules & biomedicine 24:61-72 PubMed37573538

2024

Aberrant expression and regulatory role of histone deacetylase 9 in vascular endothelial cell injury in intracranial aneurysm.

Applications

Unspecified application

Species

Unspecified reactive species

Jingwei Sun,Langfeng Zhang,Quanjiang Cheng,Yajun Wu

Immunity, inflammation and disease 11:e1043 PubMed37904708

2023

Mechanism of KLF9 in airway inflammation in chronic obstructive pulmonary.

Applications

Unspecified application

Species

Unspecified reactive species

Peijie Gu,Zhen Wang,Xin Yu,Nan Wu,Liang Wu,Yihang Li,Xiaodong Hu

Thoracic cancer 14:2579-2590 PubMed37548102

2023

SETD1A-mediated H3K4me3 methylation upregulates lncRNA HOXC-AS3 and the binding of HOXC-AS3 to EP300 and increases EP300 stability to suppress the ferroptosis of NSCLC cells.

Applications

Unspecified application

Species

Unspecified reactive species

Zhenliang Shi,Hao Zhang,Yimeng Shen,Sipei Zhang,Xun Zhang,Yijun Xu,Daqiang Sun

Environmental toxicology 38:2545-2559 PubMed37471637

2023

Regulatory mechanism of RNA binding motif protein 15-mediated N methyladenosine modification in proliferation, invasion, and migration of colorectal cancer cells.

Applications

Unspecified application

Species

Unspecified reactive species

Jiangmu Chen

FASEB journal : official publication of the Federation of American Societies for Experimental Biology 37:e22779 PubMed36723798

2023

ANP promotes HTR-8/SVneo cell invasion by upregulating protein kinase N 3 via autophagy inhibition.

Applications

Unspecified application

Species

Unspecified reactive species

Nan Chu,Yao Tang,Cheng-Jie Wang,Jiang-Nan Pei,Shou-Ling Luo,Yi Yu,Zhen-Zhen Liu,Hai-Yan Liu,Xue-Min Qiu,Ling Wang,Da-Jin Li,Wei-Rong Gu

Open medicine (Warsaw, Poland) 16:1564-1582 PubMed34722892

2021

Superenhancer-transcription factor regulatory network in malignant tumors.

Applications

Unspecified application

Species

Unspecified reactive species

Yuan Liang,Linlin Li,Tian Xin,Binru Li,Dalin Zhang

Molecular medicine reports 9:837-42 PubMed24398533

2014

Generation of induced pluripotent stem cells using skin fibroblasts from patients with myocardial infarction under feeder-free conditions.

Applications

Unspecified application

Species

Unspecified reactive species

Jun-Quan Li,Ming Cheng,Wei-Chen Tian,Jian Zhang

The Journal of biological chemistry 282:14073-82 PubMed17355974

2007

Transcriptional up-regulation of inhibitory PAS domain protein gene expression by hypoxia-inducible factor 1 (HIF-1): a negative feedback regulatory circuit in HIF-1-mediated signaling in hypoxic cells.

Applications

Unspecified application

Species

Unspecified reactive species

Yuichi Makino,Rie Uenishi,Kensaku Okamoto,Tsubasa Isoe,Osamu Hosono,Hirotoshi Tanaka,Arvydas Kanopka,Lorenz Poellinger,Masakazu Haneda,Chikao Morimoto
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com